The world's first anti-leprosy vaccine, 'MW-vaccine', which has been developed in India, will be released for commercial use today. The National Institute of Immunology (NII) developed the vaccine, under a project of the department of biotechnology, after working on it for almost 10 years. Last week, the vaccine was cleared for commercial use by the Drug Controller of India after extensive clinical trials.